"Designing Growth Strategies is in our DNA"

Atrial Fibrillation Market Size, Share & Industry Analysis, By Drug Class (Anticoagulants and Antiarrhythmic Drugs), By Route of Administration (Oral, Intravenous, and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and Regional Forecast, 2025-2032

Last Updated: April 28, 2025 | Format: PDF | Report ID: FBI108921

 

Atrial Fibrillation Market

Request Now
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence/Incidence of Arrhythmia, Key Region, 2021/2024
    2. Key Industry Developments - Mergers, Partnerships, Acquisitions
    3. New Product Launches by Key Players
    4. Impact of COVID-19 on Atrial Fibrillation Market
  5. Global Atrial Fibrillation Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anticoagulants
      2. Anti-arrhythmic Drugs
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Atrial Fibrillation Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anticoagulants
      2. Anti-arrhythmic Drugs
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Drug Class
      2. Canada
        1. By Drug Class
  7. Europe Atrial Fibrillation Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anticoagulants
      2. Anti-arrhythmic Drugs
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Germany
        1. By Drug Class
      2. U.K.
        1. By Drug Class
      3. France
        1. By Drug Class
      4. Spain
        1. By Drug Class
      5. Italy
        1. By Drug Class
      6. Scandinavia
        1. By Drug Class
      7. Rest of Europe
        1. By Drug Class
  8. Asia Pacific Atrial Fibrillation Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anticoagulants
      2. Anti-arrhythmic Drugs
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
        1. By Drug Class
      2. China
        1. By Drug Class
      3. India
        1. By Drug Class
      4. Australia
        1. By Drug Class
      5. Southeast Asia
        1. By Drug Class
      6. Rest of Asia Pacific
        1. By Drug Class
  9. Latin America Atrial Fibrillation Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anticoagulants
      2. Anti-arrhythmic Drugs
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
        1. By Drug Class
      2. Mexico
        1. By Drug Class
      3. Rest of Latin America
        1. By Drug Class
  10. Middle East & Africa Atrial Fibrillation Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Anticoagulants
      2. Anti-arrhythmic Drugs
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
        1. By Drug Class
      2. South Africa
        1. By Drug Class
      3. Rest of Middle East & Africa
        1. By Drug Class
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. Bristol-Myers Squibb Company
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Sanofi
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Eisai Co., Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Johnson & Johnson
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Daiichi Sankyo, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Par Pharmaceutical
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Bayer AG
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Pfizer Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: Global Atrial Fibrillation Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Atrial Fibrillation Market Value Share (%), by Drug Class, 2024 & 2032

Figure 3: Global Atrial Fibrillation Market Value Share (%), by Route of Administration, 2024 & 2032

Figure 4: Global Atrial Fibrillation Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 5: Global Atrial Fibrillation Market Value Share (%), by Region, 2024 & 2032

Figure 6: North America Atrial Fibrillation Market Value (USD billion), by Drug Class, 2024 & 2032

Figure 7: North America Atrial Fibrillation Market Value Share (%), by Drug Class, 2024

Figure 8: North America Atrial Fibrillation Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 9: North America Atrial Fibrillation Market Value Share (%), by Route of Administration, 2024

Figure 10: North America Atrial Fibrillation Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 11: North America Atrial Fibrillation Market Value Share (%), by Distribution Channel, 2024

Figure 12: North America Atrial Fibrillation Market Value (USD billion), By Country, 2024 & 2032

Figure 13: North America Atrial Fibrillation Market Value Share (%), By Country, 2024

Figure 14: Europe Atrial Fibrillation Market Value (USD billion), by Drug Class, 2024 & 2032

Figure 15: Europe Atrial Fibrillation Market Value Share (%), by Drug Class, 2024

Figure 16: Europe Atrial Fibrillation Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 17: Europe Atrial Fibrillation Market Value Share (%), by Route of Administration, 2024

Figure 18: Europe Atrial Fibrillation Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 19: Europe Atrial Fibrillation Market Value Share (%), by Distribution Channel, 2024

Figure 20: Europe Atrial Fibrillation Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 21: Europe Atrial Fibrillation Market Value Share (%), By Country/ Sub-region, 2024

Figure 22: Asia Pacific Atrial Fibrillation Market Value (USD billion), by Drug Class, 2024 & 2032

Figure 23: Asia Pacific Atrial Fibrillation Market Value Share (%), by Drug Class y, 2024

Figure 24: Asia Pacific Atrial Fibrillation Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 25: Asia Pacific Atrial Fibrillation Market Value Share (%), by Route of Administration, 2024

Figure 26: Asia Pacific Atrial Fibrillation Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 27: Asia Pacific Atrial Fibrillation Market Value Share (%), by Distribution Channel, 2024

Figure 28: Asia Pacific Atrial Fibrillation Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 29: Asia Pacific Atrial Fibrillation Market Value Share (%), By Country/ Sub-region, 2024

Figure 30: Latin America Atrial Fibrillation Market Value (USD billion), by Drug Class, 2024 & 2032

Figure 31: Latin America Atrial Fibrillation Market Value Share (%), by Drug Class, 2024

Figure 32: Latin America Atrial Fibrillation Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 33: Latin America Atrial Fibrillation Market Value Share (%), by Route of Administration, 2024

Figure 34: Latin America Atrial Fibrillation Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 35: Latin America Atrial Fibrillation Market Value Share (%), by Distribution Channel, 2024

Figure 36: Latin America Atrial Fibrillation Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 37: Latin America Atrial Fibrillation Market Value Share (%), By Country/ Sub-region, 2024

Figure 38: Middle East & Africa Atrial Fibrillation Market Value (USD billion), by Drug Class, 2024 & 2032

Figure 39: Middle East & Africa Atrial Fibrillation Market Value Share (%), by Drug Class, 2024

Figure 40: Middle East & Africa Atrial Fibrillation Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 41: Middle East & Africa Atrial Fibrillation Market Value Share (%), by Route of Administration, 2024

Figure 42: Middle East & Africa Atrial Fibrillation Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 43: Middle East & Africa Atrial Fibrillation Market Value Share (%), by Distribution Channel, 2024

Figure 44: Middle East & Africa Atrial Fibrillation Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 45: Middle East & Africa Atrial Fibrillation Market Value Share (%), By Country/ Sub-region, 2024

Figure 46: Global Atrial Fibrillation Market Share (%), By Company, 2024

Table 1: Global Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 2: Global Atrial Fibrillation Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 3: Global Atrial Fibrillation Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 4: Global Atrial Fibrillation Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 5: North America Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 6: North America Atrial Fibrillation Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 7: North America Atrial Fibrillation Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 8: North America Atrial Fibrillation Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 9: U.S. Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 10: Canada Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 11: Europe Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 12: Europe Atrial Fibrillation Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 13: Europe Atrial Fibrillation Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 14: Europe Atrial Fibrillation Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 15: Germany Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 16: U.K. Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 17: France Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 18: Italy Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 19: Spain Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 20: Scandinavia Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 21: Rest of Europe Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 22: Asia Pacific Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 23: Asia Pacific Atrial Fibrillation Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 24: Asia Pacific Atrial Fibrillation Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 25: Asia Pacific Atrial Fibrillation Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 26: Japan Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 27: India Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 28: China Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 29: Australia Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 30: Southeast Asia Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 31: Rest of Asia Pacific Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 32: Latin America Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 33: Latin America Atrial Fibrillation Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 34: Latin America Atrial Fibrillation Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 35: Latin America Atrial Fibrillation Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 36: Brazil Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 37: Mexico Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 38: Rest of Latin America Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 39: Middle East & Africa Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 40: Middle East & Africa Atrial Fibrillation Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 41: Middle East & Africa Atrial Fibrillation Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 42: Middle East & Africa Atrial Fibrillation Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 43: GCC Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 44: South Africa Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 45: Rest of Middle East & Africa Atrial Fibrillation Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Atrial Fibrillation Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2024
  • 2019-2023
  • 143
GET A FREE SAMPLE
    The free sample includes data points such as market estimates, growth rate, size of the largest region and segment of the market.
Consulting Services
    How will you benefit from our consulting services ?